Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant fusion protein linking human coagulation factor VIIa with human albumin

EU orphan designation number: EU/3/11/855   
Active ingredient: Recombinant fusion protein linking human coagulation factor VIIa with human albumin
Indication: Treatment of haemophilia A
Sponsor: CSL Behring GmbH
Emil-von-Behring-Straße 76, 35041 Marburg, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/04/2011 Orphan designation EMA/OD/132/10 (2011)2842 of 15/04/2011